The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.
about
Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic reviewPrevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiariesUnderstanding the burden of tuberculosis among American Indians/Alaska Natives in the U.S.: a validation studySystematic review of validation studies of the use of administrative data to identify serious infections.Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositisAccuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis.The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United StatesSpatial clusters of nontuberculous mycobacterial lung disease in the United StatesTuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritisPulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae.Geographic Distribution of Nontuberculous Mycobacterial Species Identified among Clinical Isolates in the United States, 2009-2013.On the Reportability of Nontuberculous Mycobacterial Disease to Public Health Authorities.Increased risk of mycobacterial infections associated with anti-rheumatic medications.Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria.
P2860
Q26752278-DDC74E2D-483E-460C-8696-E5ED1A9B20FDQ28729217-4FEF6840-3053-4257-B8AD-C3C1B277A1F7Q33681111-B25BB96C-8BED-40EA-87D3-95D467CFDB87Q34555474-00403066-90A0-40EF-9C4D-C3B51C56A2B5Q35121799-694CC3CF-50AD-417F-9EDC-445D4A537199Q35498610-8C608938-B934-4380-9B64-228B7DE57488Q36019747-2B665462-CCBA-4157-8CFC-B49E3DE54831Q36232419-342E2768-C77D-4365-B256-A70E5EC55455Q36345297-3C8F7E7A-945F-4F4D-BCB8-B59AD5880B42Q36968737-3F9BDABE-3AF7-410C-A49C-9EE5BDC9EAD0Q37739668-9FC12A04-3325-4B76-846B-DF556E91327FQ38192553-060703D4-6636-4395-ABF5-78EF67B1294EQ38620110-421B4DA8-4EC6-49FA-A384-63DAE4480F8FQ40402426-64081B65-BFAD-4CA3-9573-D58CB63E5A9BQ41015996-5834EA89-FB65-4161-B2D0-851A60E94264Q41993428-5C60FC47-D663-484A-8870-946D2A6DD529
P2860
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The reliability of diagnostic ...... tumor necrosis factor therapy.
@ast
The reliability of diagnostic ...... tumor necrosis factor therapy.
@en
type
label
The reliability of diagnostic ...... tumor necrosis factor therapy.
@ast
The reliability of diagnostic ...... tumor necrosis factor therapy.
@en
prefLabel
The reliability of diagnostic ...... tumor necrosis factor therapy.
@ast
The reliability of diagnostic ...... tumor necrosis factor therapy.
@en
P2093
P2860
P356
P1476
The reliability of diagnostic ...... -tumor necrosis factor therapy
@en
P2093
Cara Varley
Donald Austin
Eric Suhler
Kevin L Winthrop
LeAnn Radcliffe
Lisa J Herrinton
Roger Baxter
P2860
P304
P356
10.1002/PDS.2049
P577
2010-12-10T00:00:00Z